ID

29596

Descripción

Hepatitis B Virus (HBV) Viral Suppression by Entecavir in Adefovir Partial Responders; ODM derived from: https://clinicaltrials.gov/show/NCT00704106

Link

https://clinicaltrials.gov/show/NCT00704106

Palabras clave

Versiones (2)
  1. 9/4/18 9/4/18 -
  2. 9/4/18 9/4/18 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

9 de abril de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Hepatitis B NCT00704106

Inglés

Eligibility Hepatitis B NCT00704106

1 formularios  
Criteria
Descripción

Criteria

age 18 years or older
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
all genders and ethnicity
Descripción

Ethnicity All

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0015031
UMLS CUI [1,2]
C0444868
positive hbsag
Descripción

Hepatitis B surface antigen positive

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0149709
hbeag positive and negative
Descripción

Hepatitis B e antigen positive | Hepatitis B e antigen negative

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0392390
UMLS CUI [2]
C0948827
pretreatment hbv dna of 10,000 copies/ml or higher (for purposes of this study, both copies and equivalent iu measurements will be recorded and analyzed)
Descripción

Pretreatment Hepatitis B DNA Measurement

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3539075
UMLS CUI [1,2]
C3641250
patients who are switched to, or prescribed, entecavir after treatment with adefovir for at least 12 weeks by the providing physician.
Descripción

Adefovir | Change of medication | Entecavir | Entecavir prescribed

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0050175
UMLS CUI [2]
C0580105
UMLS CUI [3]
C0971023
UMLS CUI [4,1]
C0971023
UMLS CUI [4,2]
C0278329
patients with and without prior lamivudine exposure will be enrolled but enrollment of lamivudine experienced cases will be limited to no more than 30 patients total
Descripción

Exposure to Lamivudine | Absence Exposure to Lamivudine

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0332157
UMLS CUI [1,2]
C0209738
UMLS CUI [2,1]
C0332197
UMLS CUI [2,2]
C0332157
UMLS CUI [2,3]
C0209738
key exclusion criteria:
Descripción

Exclusion Criteria Main

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0680251
UMLS CUI [1,2]
C1542147
patients who refused to consent to the study
Descripción

Informed Consent Refused

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C1705116
patients younger than 18
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
vulnerable subjects such as pregnant women, prisoners, employees, patients with significant cognitive deficits.
Descripción

Vulnerable adult | Pregnant Women | Prisoners | Employee | Patients Impaired cognition

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1562367
UMLS CUI [2]
C0033011
UMLS CUI [3]
C0033167
UMLS CUI [4]
C0599987
UMLS CUI [5,1]
C0030705
UMLS CUI [5,2]
C0338656
patients with prior exposure to another nucleoside for more than 2 weeks. those with prior exposure to lamivudine will be enrolled under conditions detailed above.
Descripción

Exposure to Nucleosides | Exception Exposure to Lamivudine

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0332157
UMLS CUI [1,2]
C0028621
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0332157
UMLS CUI [2,3]
C0209738
hiv co-infection
Descripción

HIV coinfection

Tipo de datos

boolean

Alias
UMLS CUI [1]
C4062778
hcv co-infection
Descripción

HCV coinfection

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1698259
hdv co-infection
Descripción

HDV Coinfection

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0011220
UMLS CUI [1,2]
C0275524
recipients of solid organ transplantation
Descripción

Solid organ transplant Recipient

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0730400
UMLS CUI [1,2]
C1709854
patients who receive high-dose steroid (60 mg/d or higher and for longer than 10 days)
Descripción

Steroids High dose

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0038317
UMLS CUI [1,2]
C0444956
Volver a la parte superior de la página

Similar models

Eligibility Hepatitis B NCT00704106

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Age
Item
age 18 years or older
boolean
C0001779 (UMLS CUI [1])
Ethnicity All
Item
all genders and ethnicity
boolean
C0015031 (UMLS CUI [1,1])
C0444868 (UMLS CUI [1,2])
Hepatitis B surface antigen positive
Item
positive hbsag
boolean
C0149709 (UMLS CUI [1])
Hepatitis B e antigen positive | Hepatitis B e antigen negative
Item
hbeag positive and negative
boolean
C0392390 (UMLS CUI [1])
C0948827 (UMLS CUI [2])
Pretreatment Hepatitis B DNA Measurement
Item
pretreatment hbv dna of 10,000 copies/ml or higher (for purposes of this study, both copies and equivalent iu measurements will be recorded and analyzed)
boolean
C3539075 (UMLS CUI [1,1])
C3641250 (UMLS CUI [1,2])
Adefovir | Change of medication | Entecavir | Entecavir prescribed
Item
patients who are switched to, or prescribed, entecavir after treatment with adefovir for at least 12 weeks by the providing physician.
boolean
C0050175 (UMLS CUI [1])
C0580105 (UMLS CUI [2])
C0971023 (UMLS CUI [3])
C0971023 (UMLS CUI [4,1])
C0278329 (UMLS CUI [4,2])
Exposure to Lamivudine | Absence Exposure to Lamivudine
Item
patients with and without prior lamivudine exposure will be enrolled but enrollment of lamivudine experienced cases will be limited to no more than 30 patients total
boolean
C0332157 (UMLS CUI [1,1])
C0209738 (UMLS CUI [1,2])
C0332197 (UMLS CUI [2,1])
C0332157 (UMLS CUI [2,2])
C0209738 (UMLS CUI [2,3])
Exclusion Criteria Main
Item
key exclusion criteria:
boolean
C0680251 (UMLS CUI [1,1])
C1542147 (UMLS CUI [1,2])
Informed Consent Refused
Item
patients who refused to consent to the study
boolean
C0021430 (UMLS CUI [1,1])
C1705116 (UMLS CUI [1,2])
Age
Item
patients younger than 18
boolean
C0001779 (UMLS CUI [1])
Vulnerable adult | Pregnant Women | Prisoners | Employee | Patients Impaired cognition
Item
vulnerable subjects such as pregnant women, prisoners, employees, patients with significant cognitive deficits.
boolean
C1562367 (UMLS CUI [1])
C0033011 (UMLS CUI [2])
C0033167 (UMLS CUI [3])
C0599987 (UMLS CUI [4])
C0030705 (UMLS CUI [5,1])
C0338656 (UMLS CUI [5,2])
Exposure to Nucleosides | Exception Exposure to Lamivudine
Item
patients with prior exposure to another nucleoside for more than 2 weeks. those with prior exposure to lamivudine will be enrolled under conditions detailed above.
boolean
C0332157 (UMLS CUI [1,1])
C0028621 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0332157 (UMLS CUI [2,2])
C0209738 (UMLS CUI [2,3])
HIV coinfection
Item
hiv co-infection
boolean
C4062778 (UMLS CUI [1])
HCV coinfection
Item
hcv co-infection
boolean
C1698259 (UMLS CUI [1])
HDV Coinfection
Item
hdv co-infection
boolean
C0011220 (UMLS CUI [1,1])
C0275524 (UMLS CUI [1,2])
Solid organ transplant Recipient
Item
recipients of solid organ transplantation
boolean
C0730400 (UMLS CUI [1,1])
C1709854 (UMLS CUI [1,2])
Steroids High dose
Item
patients who receive high-dose steroid (60 mg/d or higher and for longer than 10 days)
boolean
C0038317 (UMLS CUI [1,1])
C0444956 (UMLS CUI [1,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial